Jennifer Poole (Image credit: Publicize)
Publicize, a digital PR company for technology startups and enterprises, has announced that executive Jennifer Poole has been promoted to Chief Revenue Officer.
Prior to being promoted to CRO, Poole—who is from the United States—served as the company’s Head of Client Acquisition.
Last month, she was named a Mentor at USC Incubator, which accelerates the development of the University of Southern California’s top student and alumni entrepreneurs through experiential education, mentorship and community.
She was earlier Country Director at Oxford Business Group, a global research and advisory company producing business intelligence on more than 35 countries. Poole worked on the ground in Kuwait where she was in charge of overseeing all aspects the country’s annual research team.
Image credit: Publicize
Founded in 2013 and headquartered in Medellin, Publicize is pursuing a mission to provide high-quality PR, editorial, and marketing services to startups and larger businesses so that they can get the exposure they need in order to grow.
Although it has grown into a company of more than 70 employees and over 100 clients, it says that it still likes to consider itself a startup, with the mentality “running through everything we do, from our continuous innovation to our anything’s possible attitude.”
Publicize has worked with notable clients including U.S.-based automation platform Liongard, digital solutions provider intive, and GPS navigation software developer Sygic.
Disclosure: This article features a member of an Espacio portfolio company.
DARPA's O-Circuit program looks to build a new class of biologically inspired computer equipped with…
As AI races into classrooms worldwide, Google is finding that the toughest lessons on how…
The push to eat bugs is not an organic movement coming from the people, but…
As Africa’s digital economy accelerates, a new partnership between the Africa Digital Assets Summit 2026…
The State of Generative AI in the Enterprise report from Menlo Ventures found that companies…
Living therapies, made of engineered immune cells – and capable of hunting down cancer, reversing…